Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000499936 | SCV000593120 | uncertain significance | not specified | 2017-02-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001364424 | SCV001560573 | likely benign | Alstrom syndrome | 2025-01-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002376917 | SCV002687471 | likely benign | Cardiovascular phenotype | 2020-01-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001364424 | SCV002082928 | uncertain significance | Alstrom syndrome | 2021-03-25 | no assertion criteria provided | clinical testing |